Love what you hear? Download the Curie app from the App Store today.

Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals.

In this episode of Curie, Matt explores the latest breakthroughs and challenges in oncology care. Learn about novel immunotherapy combinations offering new hope for advanced melanoma patients. Dive into long-term findings solidifying trastuzumab emtansine (T-DM1) as the gold standard for certain HER2-positive breast cancer cases. Finally, discover how financial barriers are impacting patient ...